Academic Journal

Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Συγγραφείς: Olde Nordkamp, LRA, Pepplinkhuizen, S, Ghani, A, Boersma, LVA, Kuschyk, J, El-Chami, MF, Behr, ER, Brouwer, TF, Kääb, S, Mittal, S, Quast, A-FBE, van der Stuijt, W, Smeding, L, de Veld, JA, Tijssen, JGP, Bijsterveld, NR, Richter, S, Brouwer, MA, de Groot, JR, Kooiman, KM, Lambiase, PD, Neuzil, P, Vernooy, K, Alings, M, Betts, TR, Bracke, FALE, Burke, MC, de Jong, JSSG, Wright, DJ, Jansen, WPJ, Whinnett, ZI, Nordbeck, P, Knaut, M, Philbert, BT, van Opstal, JM, Chicos, AB, Allaart, CP, Borger van der Burg, AE, Dizon, JM, Miller, MA, Nemirovsky, D, Surber, R, Upadhyay, GA, Weiss, R, de Weger, A, Wilde, AAM, Knops, RE, PRAETORIAN Investigators
Στοιχεία εκδότη: American Heart Association
Έτος έκδοσης: 2024
Συλλογή: St George's University of London: Repository
Περιγραφή: BACKGROUND: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The PRAETORIAN (Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) trial demonstrated that the S-ICD is noninferior to the transvenous ICD (TV-ICD) with regard to the combined end point of IAS and complications. This secondary analyses evaluates all IAT in the PRAETORIAN trial. METHODS: This international, multicenter trial randomized 849 patients with an indication for ICD therapy between S-ICD (n=426) and TV-ICD therapy (n=423). ICD programming was mandated by protocol. All analysis were performed in the modified intention-to-treat population. RESULTS: In both groups 42 patients experienced IAT (48-month Kaplan-Meier estimated cumulative incidence, 9.9% and 10.1%, respectively; hazard ratio (HR), 0.99 [95% CI, 0.65-1.52]; P=0.97). There was no significant difference in patients experiencing IAS between both groups (P=0.14). In the S-ICD group, 81 IAT episodes with 124 IAS and 1 inappropriate antitachycardia pacing occurred versus 89 IAT episodes with 130 IAS and 124 inappropriate antitachycardia pacing in the TV-ICD group. IAT episodes were most frequently caused by supraventricular tachycardias in the TV-ICD group (n=83/89) versus cardiac oversensing in the S-ICD group (n=40/81). In the TV-ICD group, a baseline heart rate >80 bpm (HR, 1.99 [95% CI, 1.05-3.76]; P=0.03), a history of atrial fibrillation (HR, 2.66 [95% CI, 1.41-5.02]; P=0.003), and smoking (HR, 2.46 [95% CI, 1.31-4.09]; P=0.005) were independent predictors for IAT. A QRS duration >120 ms was an independent predictor for IAT caused by cardiac oversensing in the S-ICD group (HR, 3.13 [95% CI, 1.34-7.31]; P=0.008). Post-IAS interventions significantly reduced IAS recurrence in both groups (P=0.046). CONCLUSIONS: There was no significant difference in IAT and ...
Τύπος εγγράφου: article in journal/newspaper
Περιγραφή αρχείου: application/pdf
Γλώσσα: English
ISSN: 1941-3084
Relation: https://openaccess.sgul.ac.uk/id/eprint/116988/1/olde-nordkamp-et-al-2024-inappropriate-therapy-and-shock-rates-between-the-subcutaneous-and-transvenous-implantable.pdf; https://openaccess.sgul.ac.uk/id/eprint/116988/6/circae-2024-012836-t-s01.pdf; Olde Nordkamp, LRA; Pepplinkhuizen, S; Ghani, A; Boersma, LVA; Kuschyk, J; El-Chami, MF; Behr, ER; Brouwer, TF; Kääb, S; Mittal, S; et al. Olde Nordkamp, LRA; Pepplinkhuizen, S; Ghani, A; Boersma, LVA; Kuschyk, J; El-Chami, MF; Behr, ER; Brouwer, TF; Kääb, S; Mittal, S; Quast, A-FBE; van der Stuijt, W; Smeding, L; de Veld, JA; Tijssen, JGP; Bijsterveld, NR; Richter, S; Brouwer, MA; de Groot, JR; Kooiman, KM; Lambiase, PD; Neuzil, P; Vernooy, K; Alings, M; Betts, TR; Bracke, FALE; Burke, MC; de Jong, JSSG; Wright, DJ; Jansen, WPJ; Whinnett, ZI; Nordbeck, P; Knaut, M; Philbert, BT; van Opstal, JM; Chicos, AB; Allaart, CP; Borger van der Burg, AE; Dizon, JM; Miller, MA; Nemirovsky, D; Surber, R; Upadhyay, GA; Weiss, R; de Weger, A; Wilde, AAM; Knops, RE; PRAETORIAN Investigators (2024) Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol, 17 (12). e012836. ISSN 1941-3084 https://doi.org/10.1161/CIRCEP.124.012836 SGUL Authors: Behr, Elijah Raphael
DOI: 10.1161/CIRCEP.124.012836
Διαθεσιμότητα: https://openaccess.sgul.ac.uk/id/eprint/116988/
https://doi.org/10.1161/CIRCEP.124.012836
Rights: cc_by_nc_nd_4
Αριθμός Καταχώρησης: edsbas.319C4F0A
Βάση Δεδομένων: BASE